Estrogen deficiency and bone loss in women with breast cancer.
Shapiro
Charles L
CL
Ohio State University Medical Center, James Cancer Hospital, Columbus, OH 43210, USA. charles.shapiro@osumc.edu
D000568:Amenorrhea / Q000097:blood / Q000139:chemically induced / Q000503:physiopathology; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D015415:Biomarkers / Q000097:blood; D015519:Bone Density / Q000187:drug effects*; D001943:Breast Neoplasms / Q000097:blood / Q000188:drug therapy* / Q000473:pathology; D017024:Chemotherapy, Adjuvant / Q000009:adverse effects; D004958:Estradiol / Q000097:blood / Q000172:deficiency*; D005260:Female; D006801:Humans; D008159:Lumbar Vertebrae / Q000187:drug effects / Q000473:pathology; D008597:Menstrual Cycle / Q000187:drug effects; D010024:Osteoporosis / Q000139:chemically induced* / Q000473:pathology; D010053:Ovary / Q000187:drug effects* / Q000378:metabolism / Q000503:physiopathology; D010384:Pelvic Bones / Q000187:drug effects / Q000473:pathology; D017697:Premenopause; D013997:Time Factors; D016896:Treatment Outcome
D015415:Biomarkers; D004958:Estradiol